Home › Stargardt Disease › California
Stargardt Disease clinical trials in California
9 studies for Stargardt Disease are looking for participants at sites in California.
A Study of AAVB-039 in Participants With Stargardt Disease (STGD1)
- Children's Hospital Los Angeles, Los Angeles
- Retina Vitreous Associates Medical Group, Los Angeles
RecruitingPhase 1/2
Ages 8 to 55 · All sexes · Updated Sep 30, 2026 · NCT07161544A Study to Learn How Stargardt-type Eye Conditions Progress in Children and Adults
- Stanford University School of Medicine, Palo Alto
- University of California Health - UC Davis, Sacramento
RecruitingObservational study
Ages 6 and older · All sexes · Updated Aug 25, 2026 · NCT07425574Phase 1 Study of C.001 in Retinal Degeneration
- Retina Vision Consultants, Beverly Hills
- Palo Alto Medical Foundation, Palo Alto
- Retinal Consultants Medical Group, Sacramento
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Aug 17, 2026 · NCT07594236Phase 1/2 Open-Label Dose-Escalation Study to Evaluate Safety of a Single Intravitreal Injection of RTx-021 in Patients With Stargardt Disease
- RayTx Clinical Site, Bakersfield
RecruitingPhase 1/2
Ages 16 and older · All sexes · Updated Apr 15, 2026 · NCT07439887Development and Evaluation of Functional Visual Field and Navigation Endpoints in Moderate to Profound Inherited Retinal Disease (DEFINE-IRD)
- Vision Research and Assessment Institute, Irvine
RecruitingObservational study
Ages 18 and older · All sexes · Updated Mar 31, 2026 · NCT07502664Prescreening Study to Identify Potential Stargardt Participants for ACDN-01 Clinical Trials (STARPATH)
- University of San Francisco, San Francisco
RecruitingObservational study
Ages 5 and older · All sexes · Updated Mar 11, 2026 · NCT06445322Study to Evaluate ACDN-01 in ABCA4-related Stargardt Retinopathy (STELLAR)
- University of San Francisco, San Francisco
RecruitingPhase 1/2
Ages 12 and older · All sexes · Updated Dec 2, 2025 · NCT06467344An Observational Study in Subjects to Follow the Progression of Stargardt Disease Type 1 (STGD1) Caused by Bi-Allelic Autosomal Recessive Mutations in the ABCA4 Gene
- Shiley Eye Institute, San Diego
RecruitingObservational study
Ages 12 to 65 · All sexes · Updated Sep 19, 2025 · NCT06435000Observational Study to Assess Endpoint Operational Feasibility & Measurement Properties in Patients with Retinal Degeneration
- Vision Research and Assessment Institute, Irvine
RecruitingObservational study
Ages 18 and older · All sexes · Updated Jan 8, 2025 · NCT06375239From ClinicalTrials.gov, data retrieved Oct 1, 2026. Each study sets its own eligibility; the study team decides who can join.